<DOC>
	<DOCNO>NCT01971463</DOCNO>
	<brief_summary>This study non-randomized , Phase 2 clinical trial design assess optical cerebral blood flow ( CBF ) response bolus normal saline . Subjects ischemic stroke within 96 hour enrollment . The study intervention one hour monitoring session . There 15 minute baseline measurement period , follow intravenous administration 500cc 0.9 % NaCl 30 minute , finally 15 minute monitor post-bolus . All study measurement cease 1 hour . Subjects followed hospitalization 7 day discharge , whichever sooner , monitor adverse event collect clinical information .</brief_summary>
	<brief_title>Bolus Saline Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<criteria>Age â‰¥ 18 year Acute ischemic stroke territory anterior , middle , posterior cerebral artery territory either side brain Study intervention initiate within 96 hour symptom onset Willingness ability sign inform consent patient legally acceptable surrogate decisionmaker Infarct limit brainstem and/or cerebellum involvement cerebral hemisphere Bihemispheric infarction acute infarct contralateral hemisphere within past 30 day Symptoms active congestive heart failure ( dyspnea , orthopnea , increase oxygen requirement ) Exacerbation congestive heart failure , require hospitalization , within past 30 day severe systolic dysfunction know ejection fraction &lt; 20 % End stage renal disease require hemodialysis creatinine clearance &lt; 20 ml/min/1.73 m2 Hemicraniectomy skull defect would interfere monitor Pregnant woman exclude . Women childbearing age must negative pregnancy test prior enrollment Participation another clinical trial Any illness condition investigator feel would pose hazard subject participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>110 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>